Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics
Clinical Microbiology Reviews · 13.03.2025 · 38 (1)
DOI: 10.1128/cmr.00128-23 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical Microbiology Reviews, erschienen am 13.03.2025. Verfasst von Jessica R Spengler und 3 weiteren Autor:innen. Beteiligte Einrichtung: Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, U…. Hauptthemen laut MEDLINE: Henipavirus Infections, Viral Vaccines, Henipavirus. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 370 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Henipaviruses were first identified 30 years ago and have since been associated with over 30 outbreaks of disease in humans. Highly pathogenic henipaviruses include Hendra virus (HeV) and Nipah virus (NiV), classified as biosafety level 4 pathogens. In addition, NiV has been listed as a priority pathogen by the World Health Organization (WHO), the Coalition for Epidemic Preparedness Innovations (CEPI), and the UK Vaccines Research and Development Network (UKVN). Here, we re-examine epidemiological, ecological, clinical, and pathobiological studies of HeV and NiV to provide a comprehensive guide of the current knowledge and application to identify and evaluate countermeasures. We also discuss therapeutic and vaccine development efforts. Furthermore, with case identification, prevention, and treatment in mind, we highlight limitations in research and recognize gaps necessitating additional studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
ORCID-Profile: Jessica R Spengler, Michael K Lo, Stephen R Welch
Zitieren
APA
Spengler, J. R., Lo, M. K., Welch, S. R., & Spiropoulou, C. F. (2025). Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics. Clinical Microbiology Reviews, 38(1). https://doi.org/10.1128/cmr.00128-23
Vancouver
Spengler JR, Lo MK, Welch SR, Spiropoulou CF. Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics. Clinical Microbiology Reviews. 2025;38(1). doi:10.1128/cmr.00128-23
BibTeX
@article{Spengler2025,
author = {Spengler, Jessica R and Lo, Michael K and Welch, Stephen R and Spiropoulou, Christina F},
title = {Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics},
journal = {Clinical Microbiology Reviews},
year = {2025},
volume = {38},
number = {1},
doi = {10.1128/cmr.00128-23}
}
EUVIMED